L'épidémie d'Ebola de Bundibugyo oblige les États-Unis à repenser l'aide

Hundreds have died in the Bundibugyo Ebola outbreak that began in the DRC and Uganda two weeks ago.

The Virus and Its Threat

Bundibugyo virus, a lesser‑known orthoebolavirus, caused the current crisis. Historically, only two outbreaks of this strain have been recorded, and its mortality rate is slightly lower than the Zaire ebolavirus that dominated the 2014‑2016 West African epidemic. Still, the disease remains a high‑consequence pathogen: infected immune cells trigger internal bleeding, organ failure, and death. Transmission requires close contact with bodily fluids or contaminated burial practices; it is not spread by casual contact.

Treatment Efforts and Gaps

Because no vaccine targets Bundibugyo, researchers are racing to test two antibody drugs and the antiviral remdesivir. These therapies are still experimental; no approved vaccine or treatment exists for this strain. The urgency is amplified by the fact that the outbreak’s spread has already reached international borders, prompting WHO to declare a public health emergency of international concern.

Policy Response and Consequences

U.S. Secretary of State Marco Rubio declared that protecting the American people is the top foreign‑policy priority, vowing to prevent any Ebola cases from entering the United States. Rubio’s stance coincides with recent U.S. cuts to foreign aid, a move that critics say could worsen the outbreak’s containment. The policy shift marks a dramatic departure from past U.S. responses, which focused on rapid deployment of medical supplies and support for local health systems.

The Bundibugyo outbreak underscores a stark reality: when a new strain emerges without a vaccine, the world’s response hinges on experimental treatments and international cooperation. As researchers push forward, the next step will be determining whether these antibody drugs and remdesivir can curb the epidemic before it spreads further.

Source: Scientists are racing to stop a type of Ebola we have no vaccine for
Domain: scientificamerican.com